2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Sunday, November 5, 2017

4:30PM-6:00PM: Abstract Number: 945

Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics I

4:30PM-6:00PM: Abstract Number: 898

B Cell Specific TLR9 Suppresses Disease in Murine Lupus

2017 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lecture

4:30PM-6:00PM: Abstract Number: 922

Biologic DMARD Prescribing Patterns in Elderly Patients with Rheumatoid Arthritis

Healthcare Disparities in Rheumatology

4:30PM-6:00PM: Abstract Number: 923

Can Education Mitigate the Effect of Poverty on Total Knee Replacement (TKR) Outcomes?

Healthcare Disparities in Rheumatology

4:30PM-6:00PM: Abstract Number: 900

Choroid Plexus Tertiary Lymphoid Structures in Lupus: A Novel Neuro-Immune Interface

2017 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lecture

4:30PM-6:00PM: Abstract Number: 946

Clinical and Serological Features of Systemic Sclerosis in a Multicenter African American Cohort: Analysis of the Genome Research in African American Scleroderma Patients Clinical Database

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics I

4:30PM-6:00PM: Abstract Number: 951

Cross Sectional Analysis of Citrullinated-Synovial Antigen-Specific CD4+ T Cells in an RA Cohort Demonstrates Antigen Based Differences in T Cell Frequency, Phenotype and the Influence of Immunotherapy

T Cell Biology and Targets in Autoimmune Disease

4:30PM-6:00PM: Abstract Number: 897

Cutaneous Lupus Is Driven By an Exaggerated Interferon Kappa Loop Which Primes for Interferon Alpha Responses

2017 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lecture

4:30PM-6:00PM: Abstract Number: 904

Deficient Autophagy Induces Lamin a/C Accumulation in Aging and Osteoarthritis

Biology and Pathology of Bone and Joint

4:30PM-6:00PM: Abstract Number: 918

Development and Validation of a Clinical Rule to Facilitate Recognition of Clinical Arthritis By General Practitioners

Epidemiology and Public Health II: Non-Genetic Risk Factors for Incident Disease

4:30PM-6:00PM: Abstract Number: 921

Discordant Patient-Physician Assessments of Disease Activity and Its Persistence Adversely Impact Quality of Life and Work Productivity in United States Hispanics with Rheumatoid Arthritis

Healthcare Disparities in Rheumatology

4:30PM-6:00PM: Abstract Number: 927

Do Familiarity with Centers for Disease Control Guidelines, Continuing Education, and Provider Characteristics Influence Adherence to Chronic Pain Management Practices and Opioid Prescribing?

ARHP Clinical Practice/Patient Care/Health Services Research

4:30PM-6:00PM: Abstract Number: 931

Dose-Response Effects of Tai Chi and Physical Therapy Exercise Interventions in Symptomatic Knee Osteoarthritis

Osteoarthritis – Clinical Aspects I: Pain and Functional Outcomes

4:30PM-6:00PM: Abstract Number: 934

Effectiveness of FX006 Intra-Articular Injection in Patients with Knee Osteoarthritis Who Present with and without Clinical Inflammation at Baseline: A Pooled Analysis of Data from 3 Double-Blind, Randomized, Parallel-Group Clinical Trials

Osteoarthritis – Clinical Aspects I: Pain and Functional Outcomes

4:30PM-6:00PM: Abstract Number: 930

Efficacy and Safety of Modified-Release Prednisone in Managing Moderate Activity SLE during Pregnancy: An Implemented Case-Control Study

ARHP Clinical Practice/Patient Care/Health Services Research

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].